2025 Vivli AMR Surveillance Data Challenge Judges Panel

Dr. Aaron Meyer is an associate professor of Bioengineering within the Henry Samueli School of Engineering and Applied Science at the University of California, Los Angeles. He is also affiliated with the Bioinformatics Interdepartmental Program, UCLA Health Jonsson Comprehensive Cancer Center, and Broad Stem Cell Research Center.

Dr. Meyer closely integrates experimental and computational techniques to measure, model, and therapeutically manipulate cell-to-cell communication. In particular, he specializes in models of multivalent and multi-specific interactions to design and optimize immune therapies. His previous work has developed new models of how antibodies interact with the innate immune system to more accurately predict their protective effect. He has also uncovered new approaches for designing therapeutic cytokines with enhanced selectivity. His current efforts include designing new strategies to steer antibody functions within the tissue environment, and both characterizing and reactivating the innate immune activities of cancer patients’ antitumor autoantibodies.

Prof. Meyer has received several awards recognizing his research and teaching. These recognitions include the Mark Foundation for Cancer Research’s Emerging Leader Award, UCLA Samueli’s 2021 Northrop Grumman Excellence in Teaching Award, and the Director’s Early Independence Award from the National Institutes of Health. Dr. Meyer received his B.S. in Bioengineering from the University of California, Los Angeles, and his Ph.D. in Biological Engineering from the Massachusetts Institute of Technology. Following his Ph.D., he started his laboratory during an independent fellowship at the Koch Institute for Integrative Cancer Research. He joined the Bioengineering Department at the University of California, Los Angeles in 2017.